Exact Sciences Announces Second Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Exact Sciences (EXAS) Misses Q2 EPS by 27c, Revenue Beats
July 28, 2021 4:09 PM EDTExact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($1.03), $0.27 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $434.8 million versus the consensus estimate of $421.28 million.
GUIDANCE:
Exact Sciences sees FY2021 revenue of $1.71-1.75 billion, versus the consensus of $1.72... More
